CVS Health Corporation (ETR:CVS)
Germany · Delayed Price · Currency is EUR 66.95
+0.30 (0.45%)
Oct 10, 2025, 5:35 PM CET
CVS Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
| 384,329 | 370,656 | 356,623 | 321,629 | 290,912 | 267,908 | Upgrade | |
Revenue Growth (YoY) | 6.21% | 3.94% | 10.88% | 10.56% | 8.59% | 4.75% | Upgrade |
Cost of Revenue | 333,195 | 321,408 | 303,345 | 267,965 | 239,991 | 219,660 | Upgrade |
Gross Profit | 51,134 | 49,248 | 53,278 | 53,664 | 50,921 | 48,248 | Upgrade |
Selling, General & Admin | 43,212 | 41,606 | 39,832 | 38,212 | 37,021 | 35,135 | Upgrade |
Other Operating Expenses | - | 1,279 | 856 | 8,336 | 1,789 | - | Upgrade |
Operating Income | 7,922 | 6,363 | 12,590 | 7,116 | 12,111 | 13,113 | Upgrade |
Interest Income | 2,312 | 2,153 | 1,153 | 838 | 1,199 | 798 | Upgrade |
Interest Expense | -3,058 | -2,958 | -2,658 | -2,287 | -2,503 | -2,907 | Upgrade |
Other Non-Operating Income (Expense) | 107 | 590 | 88 | 169 | -270 | -1,234 | Upgrade |
Total Non-Operating Income (Expense) | -639 | -215 | -1,417 | -1,280 | -1,574 | -3,343 | Upgrade |
Pretax Income | 7,283 | 6,148 | 11,173 | 5,836 | 10,537 | 9,770 | Upgrade |
Provision for Income Taxes | 2,006 | 1,562 | 2,805 | 1,509 | 2,548 | 2,569 | Upgrade |
Net Income | 4,531 | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 | Upgrade |
Minority Interest in Earnings | 42 | 28 | -24 | -16 | 12 | -13 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | -9 | Upgrade |
Net Income to Common | 4,531 | 4,614 | 8,344 | 4,311 | 8,001 | 7,179 | Upgrade |
Net Income Growth | -36.98% | -44.70% | 93.55% | -46.12% | 11.45% | 8.21% | Upgrade |
Shares Outstanding (Basic) | 1,262 | 1,259 | 1,285 | 1,312 | 1,319 | 1,309 | Upgrade |
Shares Outstanding (Diluted) | 1,264 | 1,262 | 1,290 | 1,323 | 1,329 | 1,314 | Upgrade |
Shares Change (YoY) | -1.06% | -2.17% | -2.49% | -0.45% | 1.14% | 0.69% | Upgrade |
EPS (Basic) | 3.60 | 3.67 | 6.49 | 3.29 | 6.07 | 5.49 | Upgrade |
EPS (Diluted) | 3.59 | 3.66 | 6.47 | 3.26 | 6.02 | 5.47 | Upgrade |
EPS Growth | -36.23% | -43.43% | 98.47% | -45.85% | 10.05% | 7.68% | Upgrade |
Free Cash Flow | 4,780 | 6,326 | 10,395 | 13,450 | 15,745 | 13,428 | Upgrade |
Free Cash Flow Growth | -24.44% | -39.14% | -22.71% | -14.58% | 17.26% | 29.23% | Upgrade |
Free Cash Flow Per Share | 3.78 | 5.01 | 8.06 | 10.17 | 11.85 | 10.22 | Upgrade |
Dividends Per Share | 2.660 | 2.660 | 2.420 | 2.200 | 2.000 | 2.000 | Upgrade |
Dividend Growth | - | 9.92% | 10.00% | 10.00% | - | - | Upgrade |
Gross Margin | 13.30% | 13.29% | 14.94% | 16.69% | 17.50% | 18.01% | Upgrade |
Operating Margin | 2.06% | 1.72% | 3.53% | 2.21% | 4.16% | 4.89% | Upgrade |
Profit Margin | 1.37% | 1.24% | 2.35% | 1.35% | 2.75% | 2.69% | Upgrade |
FCF Margin | 1.24% | 1.71% | 2.91% | 4.18% | 5.41% | 5.01% | Upgrade |
EBITDA | 7,922 | 6,363 | 12,590 | 7,116 | 12,111 | 13,113 | Upgrade |
EBIT | 7,922 | 6,363 | 12,590 | 7,116 | 12,111 | 13,113 | Upgrade |
EBIT Margin | 2.06% | 1.72% | 3.53% | 2.21% | 4.16% | 4.89% | Upgrade |
Effective Tax Rate | 27.54% | 25.41% | 25.11% | 25.86% | 24.18% | 26.29% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.